ID: ALA5270983

Max Phase: Preclinical

Molecular Formula: C31H30F6N10O5

Molecular Weight: 508.59

Associated Items:

Representations

Canonical SMILES:  COc1ccc(Cn2nc(-c3ccc(/C=N/NC(=N)N)cc3)cc2-c2ccc(/C=N/NC(=N)N)cc2)cc1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

Standard InChI:  InChI=1S/C27H28N10O.2C2HF3O2/c1-38-23-12-6-20(7-13-23)17-37-25(22-10-4-19(5-11-22)16-33-35-27(30)31)14-24(36-37)21-8-2-18(3-9-21)15-32-34-26(28)29;2*3-2(4,5)1(6)7/h2-16H,17H2,1H3,(H4,28,29,34)(H4,30,31,35);2*(H,6,7)/b32-15+,33-16+;;

Standard InChI Key:  ZTRZCOVUZKXXSU-KTMKIAGUSA-N

Associated Targets(Human)

Amiloride-sensitive cation channel 2, neuronal 57 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Acid-sensing ion channel 1 41 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Acid-sensing ion channel 2 38 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cortical neurone 598 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 508.59Molecular Weight (Monoisotopic): 508.2448AlogP: 2.91#Rotatable Bonds: 9
Polar Surface Area: 175.57Molecular Species: NEUTRALHBA: 7HBD: 6
#RO5 Violations: 2HBA (Lipinski): 11HBD (Lipinski): 8#RO5 Violations (Lipinski): 3
CX Acidic pKa: CX Basic pKa: 6.21CX LogP: 3.56CX LogD: 3.53
Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.12Np Likeness Score: -1.14

References

1. Gornati D, Ciccone R, Vinciguerra A, Ippati S, Pannaccione A, Petrozziello T, Pizzi E, Hassan A, Colombo E, Barbini S, Milani M, Caccavone C, Randazzo P, Muzio L, Annunziato L, Menegon A, Secondo A, Mastrangelo E, Pignataro G, Seneci P..  (2021)  Synthesis and Characterization of Novel Mono- and Bis-Guanyl Hydrazones as Potent and Selective ASIC1 Inhibitors Able to Reduce Brain Ischemic Insult.,  64  (12.0): [PMID:34097384] [10.1021/acs.jmedchem.1c00305]

Source